Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Po-Yi Paul Su, Lingyi Zhang, Liangliang He, Na Zhao & Zhonghui Guan. (2022) The Role of Neuro-Immune Interactions in Chronic Pain: Implications for Clinical Practice. Journal of Pain Research 15, pages 2223-2248.
Read now
Read now
Paul M Overton, Natalie Shalet, Fabian Somers & Jeffrey A Allen. (2021) Patient Preferences for Subcutaneous versus Intravenous Administration of Treatment for Chronic Immune System Disorders: A Systematic Review. Patient Preference and Adherence 15, pages 811-834.
Read now
Read now
Ana Teresa Melo, Raquel Campanilho-Marques & João Eurico Fonseca. (2021) Golimumab (anti-TNF monoclonal antibody): where we stand today. Human Vaccines & Immunotherapeutics 17:6, pages 1586-1598.
Read now
Read now
Francesco Carubbi, Rosaria Fidanza, Maria Palmieri, Alessandra Ventura, Sara Tambone, Paola Cipriani, Roberto Giacomelli & Maria Concetta Fargnoli. (2020) Safety and efficacy of certolizumab pegol in a real-life cohort of patients with psoriasis and psoriatic arthritis. Journal of Dermatological Treatment 31:7, pages 692-697.
Read now
Read now
Maria Esposito, Francesco Carubbi, Alessandro Giunta, Alessia Alunno, Roberto Giacomelli & Maria Concetta Fargnoli. (2020) Certolizumab pegol for the treatment of psoriatic arthritis and plaque psoriasis. Expert Review of Clinical Immunology 16:2, pages 119-128.
Read now
Read now
Akimichi Morita, Ryuhei Okuyama, Norito Katoh, Chiharu Tateishi, Koji Masuda, Toshifumi Komori, Eisaku Ogawa, Takamitsu Makino, Emi Nishida, Shohei Nishimoto, Kenzo Muramoto, Daisuke Tsuruta & Hironobu Ihn. (2020) Efficacy and safety of adalimumab in Japanese patients with psoriatic arthritis and inadequate response to non-steroidal anti-inflammatory drugs (NSAIDs): A prospective, observational study. Modern Rheumatology 30:1, pages 155-165.
Read now
Read now
Ennio Lubrano, Silvia Scriffignano & Fabio Massimo Perrotta. (2019) TNF-alpha inhibitors for the six treatment targets of psoriatic arthritis. Expert Review of Clinical Immunology 15:12, pages 1303-1312.
Read now
Read now
Thorvardur Jon Love & Arthur Kavanaugh. (2018) Golimumab in the treatment of psoriatic arthritis. Expert Review of Clinical Immunology 14:11, pages 893-898.
Read now
Read now
Articles from other publishers (25)
Aliki I. Venetsanopoulou, Konstantina Mavridou, Paraskevi V. Voulgari & Alexandros A. Drosos. (2023) Cutaneous immune-related phenomena in patients with inflammatory arthritides treated with biological therapies: Clinical and pathophysiological considerations. Seminars in Arthritis and Rheumatism 63, pages 152272.
Crossref
Crossref
Mahnuma Mahfuz Estee, Flavia M. Cicuttini, Matthew J. Page, Anita E. Wluka & Yuanyuan Wang. (2023) Efficacy of tumor necrosis factor inhibitors in hand osteoarthritis: A systematic review and meta-analysis of randomized controlled trials. Osteoarthritis and Cartilage Open 5:4, pages 100404.
Crossref
Crossref
Ahmed Safi Vahidy, Faizan Niaz, Samiuddin Tariq, Irtebaat Fatima, Yusra Afzal & Abdulqadir J. Nashwan. (2023) IL-23 Inhibitors to treat psoriatic arthritis: A systematic review & meta-analysis of randomized controlled trials. Clinical Immunology Communications 4, pages 7-22.
Crossref
Crossref
Anna Michalak-Stoma, Katarzyna Walczak, Michał Adamczyk, Małgorzata Kowal & Dorota Krasowska. (2023) Selected miRNA and Psoriasis—Cardiovascular Disease (CVD)—Overweight/Obesity Network—A Pilot Study. International Journal of Molecular Sciences 24:18, pages 13916.
Crossref
Crossref
Bong-Woo Lee & Su-Jin Moon. (2023) Inflammatory Cytokines in Psoriatic Arthritis: Understanding Pathogenesis and Implications for Treatment. International Journal of Molecular Sciences 24:14, pages 11662.
Crossref
Crossref
Agathe Denis, Cédric Sztejkowski, Laurent Arnaud, Guillaume Becker & Renaud Felten. (2023) The 2023 pipeline of disease-modifying antirheumatic drugs (DMARDs) in clinical development for spondyloarthritis (including psoriatic arthritis): a systematic review of trials. RMD Open 9:3, pages e003279.
Crossref
Crossref
Sonia Sundanum, Carl Orr & Douglas Veale. (2023) Targeted Therapies in Psoriatic Arthritis—An Update. International Journal of Molecular Sciences 24:7, pages 6384.
Crossref
Crossref
Philippa D. K. Curry, Andrew P. Morris, Anne Barton & James Bluett. (2022) Do genetics contribute to TNF inhibitor response prediction in Psoriatic Arthritis?. The Pharmacogenomics Journal 23:1, pages 1-7.
Crossref
Crossref
Michael Ruberson Ribeiro da Silva, Jéssica Barreto Ribeiro dos Santos, Adriana Maria Kakehasi, Alessandra Maciel Almeida, Pedro Ricardo Kömel Pimenta, Juliana Alvares-Teodoro & Francisco de Assis Acurcio. (2022) First-line biologic therapy with tumor necrosis factor inhibitors for psoriatic arthritis: a prospective observational study. Sao Paulo Medical Journal 140:6, pages 787-797.
Crossref
Crossref
Giada De Benedittis, Andrea Latini, Cinzia Ciccacci, Paola Conigliaro, Paola Triggianese, Mauro Fatica, Lucia Novelli, Maria Sole Chimenti & Paola Borgiani. (2022) Impact of TRAF3IP2, IL10 and HCP5 Genetic Polymorphisms in the Response to TNF-i Treatment in Patients with Psoriatic Arthritis. Journal of Personalized Medicine 12:7, pages 1094.
Crossref
Crossref
David E. Muench, Zhe Sun, Anchal Sharma, Crystal Tang, Jordan S. Crampton, Christopher Lao, Kara Kersjes, William Chang & Songqing Na. (2022) A Pathogenic Th17/CD38+ Macrophage Feedback Loop Drives Inflammatory Arthritis through TNF-α. The Journal of Immunology 208:6, pages 1315-1328.
Crossref
Crossref
E. L. NasonovT. V. Korotaeva & C. F. Selmi. (2022) Prospects for the use of monoclonal antibodies to interleukin 23 Gusеlkumab in psoriatic arthritis: New data. Rheumatology Science and Practice 60:1, pages 80-90.
Crossref
Crossref
Sneha Patel & Anand Kumthekar. (2021) Psoriatic Arthritis: The Influence of Co-morbidities on Drug Choice. Rheumatology and Therapy 9:1, pages 49-71.
Crossref
Crossref
Rahul Sahu, Arvind Ganapati & Ashish Jacob Mathew. 2022. Handbook of Biologics for Rheumatological Disorders. Handbook of Biologics for Rheumatological Disorders
31
53
.
Anna Campanati, Andrea Marani, Emanuela Martina, Federico Diotallevi, Giulia Radi & Annamaria Offidani. (2021) Psoriasis as an Immune-Mediated and Inflammatory Systemic Disease: From Pathophysiology to Novel Therapeutic Approaches. Biomedicines 9:11, pages 1511.
Crossref
Crossref
S.L. Jyothi, K.L. Krishna, V.K. Ameena Shirin, Renu Sankar, K. Pramod & H.V. Gangadharappa. (2021) Drug delivery systems for the treatment of psoriasis: Current status and prospects. Journal of Drug Delivery Science and Technology 62, pages 102364.
Crossref
Crossref
Uwe Wollina, Massimo Fioranelli, Mohamad Goldust & Torello Lotti. (2020)
Psoriatic arthritis and
COVID
‐19 pandemic: Consequences in medical treatment?
. Dermatologic Therapy 33:5.
Crossref
Crossref
Giovanni Cagnotto, Michele Compagno, Carlo Alberto Scire & Matteo Bruschettini. (2020) Tumor necrosis factor (TNF) inhibitors for the treatment of psoriatic arthritis. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Salvatore D'Angelo, Fabrizio Cantini, Roberta Ramonda, Luca Cantarini, Antonio Carletto, Maria Sole Chimenti, Andrea Delle Sedie, Rosario Foti, Roberto Gerli, Claudia Lomater, Ennio Lubrano, Antonio Marchesoni, Alen Zabotti, Carlo Salvarani, Rossana Scrivo, Raffaele Scarpa, Giuseppina Tramontano, Carlotta Nannini, Mariagrazia Lorenzin, Marta Fabbroni, Federica Martinis, Roberto Perricone, Linda Carli, Elisa Visalli, Guido Rovera, Fabio Massimo Perrotta, Luca Quartuccio, Alessio Altobelli, Luisa Costa, Laura Niccoli, Augusta Ortolan & Francesco Caso. (2019) Effectiveness of Adalimumab for the Treatment of Psoriatic Arthritis: An Italian Real-Life Retrospective Study. Frontiers in Pharmacology 10.
Crossref
Crossref
Luisa Costa, Roberta Ramonda, Augusta Ortolan, Marta Favero, Rosario Foti, Elisa Visalli, Marco Rossato, Fabio Cacciapaglia, Giovanni Lapadula & Raffaele Scarpa. (2019) Psoriatic arthritis and obesity: the role of anti-IL-12/IL-23 treatment. Clinical Rheumatology 38:9, pages 2355-2362.
Crossref
Crossref
Joseph F. Merola & Alexis Ogdie. (2019)
SEAM
‐PsA: Seems Like Methotrexate Works in Psoriatic Arthritis?
. Arthritis & Rheumatology 71:7, pages 1027-1029.
Crossref
Crossref
A. Vultaggio, F. Nencini, A. Carraresi, S. Pratesi, R. Movérare, C. Eriksson, L. Venemalm, E. Maggi & A. Matucci. (2018) IgG4 anti‐infliximab in treated patients: Clinical impact and temporal evolution. Allergy 73:11, pages 2172-2181.
Crossref
Crossref
Michael Ruberson Ribeiro da Silva, Jéssica Barreto Ribeiro dos Santos, Alessandra Maciel Almeida, Adriana Maria Kakehasi, Haliton Alves de Oliveira Junior, Juliana Álvares-Teodoro & Francisco de Assis Acurcio. (2018) Effectiveness and safety of anti-TNF in psoriatic arthritis patients in Brazil: a post-incorporation analysis. Journal of Comparative Effectiveness Research 7:10, pages 989-1000.
Crossref
Crossref
Gaetano Zizzo, Elisa Gremese & Gianfranco Ferraccioli. (2018) Abatacept in the treatment of psoriatic arthritis: biological and clinical profiles of the responders. Immunotherapy 10:9, pages 807-821.
Crossref
Crossref
Margaret Coutts, Rowena Soriano, Rajendran Naidoo & Habib Torfi. (2017) Umbilical cord blood stem cell treatment for a patient with psoriatic arthritis. World Journal of Stem Cells 9:12, pages 235-240.
Crossref
Crossref